Read more

February 19, 2024
4 min watch
Save

VIDEO: Dextenza demonstrates positive real-world safety

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Steven M. Silverstein, MD, FACS, discusses safety data for Dextenza for the treatment of perioperative ocular pain and inflammation and allergic conjunctivitis.

Data collected from the IRIS Registry showed low adverse rates in more than 50,000 patients implanted with Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) that were “nearly identical” compared with results in patients who received topical drop therapy.

“The use of a dexamethasone insert perioperatively or to use in the clinic for postoperative steroid delivery or the use of dexamethasone for allergy relief of signs and symptoms is very, very safe and very easy to do,” Silverstein said. “I encourage you: If you haven’t already, try it. You’ll really, really enjoy this.”